TC
BCYC

TownSquare Capital’s Bicycle Therapeutics BCYC Stock Holding History

TownSquare Capital’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-7,088
Closed -$311K – 719
2022
Q1 		$311K Sell
7,088
-94
-1% -$4.39K 0.01% 580
2021
Q4 		$437K Sell
7,182
-605
-8% -$33.4K 0.01% 528
2021
Q3 		$324K Sell
7,787
-41
-0.5% -$1.43K 0.01% 537
2021
Q2 		$250K Buy
+7,828
New +$237K 0.01% 534

Other funds holding BCYC

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

TownSquare Capital's BCYC Position: Q2 2022 in Review

TownSquare Capital sold out of Bicycle Therapeutics (BCYC) in Q2 2022, closing a stake of 7,088 shares — an estimated $311K sold.

TownSquare Capital first reported a position in BCYC in Q2 2021 and held it in 4 quarters. The position peaked at $437K in Q4 2021. 81 funds tracked by Wall St. Rank hold BCYC as of Q2 2022.

  • TownSquare Capital reported no remaining Bicycle Therapeutics position as of Q2 2022 after selling out during the quarter.
  • TownSquare Capital sold 7,088 Bicycle Therapeutics shares in Q2 2022, an estimated $311K.
  • TownSquare Capital first reported a position in Bicycle Therapeutics in Q2 2021 and held it in 4 quarters.
  • TownSquare Capital's Bicycle Therapeutics position peaked at $437K in Q4 2021.
  • 81 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q2 2022.

Based on TownSquare Capital's 13F filing for Q2 2022, filed 8 Aug 2022.